Latest news for Argentum 47 (OTC:ARGQ) Stock

Argentum 47 Inc provides technology services marketing solutions and independent financial advisory services. It engaged in three primary business industries: Technology, Web Based Services, and Marketing Solutions. Its technology offering includes its proprietary AI (artificial intelligence) solutions and automation. Its web-based services include data management, storage, and blockchain. Its Marketing solutions include B2B and B2C generation marketing solutions.

News

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

General

AONCF

APTY

ARGQ

ARST

BDCO

BDRAF

BDRBF

CHYHY

CNTMF

COWI

FLDPF

FUTL

GARB

GOTRF

GWRRF

HESG

HLFDF

IMBI

INND

KEQU

LIXT

MINE

ORAN

ORVRF

RNLSY

SGRWF

SVSN

TBEV

TGRO

UAMA

ALIZY

SNNAQ

Stocks That Hit 52-Week Lows On Thursday

Argentum 47 Inc

QCR Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCRH#NASDAQ">QCRH</a>) released its Q4 earnings on Wednesday, January 22, 2025 at 04:05 PM.
Here's what's important from the earnings announcement.
<h3>Earnings</h3>
QCR Hldgs beat estimated earnings by 10.0%, reporting an EPS of $1.93 versus an estimate of $1.76.
Revenue was up $5.47 million from the same period last year.
<h3>Earnings History Overview</h3>
Last quarter the company beat on EPS by $0.26 which was followed by a 0.0% increase in the share price the next day.
Here's a look at QCR Hldgs's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.52</td>
<td>1.40</td>
<td>1.30</td>
<td>1.35</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.78</td>
<td>1.73</td>
<td>1.59</td>
<td>1.97</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>61.47M</td>
<td>65.25M</td>
<td>63.77M</td>
<td>58.53M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>59.72M</td>
<td>56.16M</td>
<td>54.70M</td>
<td>55.74M</td>
</tr>
</tbody>
</table>

To track all earnings releases for QCR Hldgs <a href="https://www.benzinga.com/quote/QCRH/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

QCRH

QCR Hldgs Earnings Analysis: Q4 Recap

Triumph Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TFIN#NASDAQ">TFIN</a>) released its Q4 earnings on Wednesday, January 22, 2025 at 04:07 PM.
Here's what's important from the earnings announcement.
<h3>Earnings</h3>
Triumph Financial missed estimated earnings by -48.0%, reporting an EPS of $0.13 versus an estimate of $0.25.
Revenue was down $2.59 million from the same period last year.
<h3>Earnings History Overview</h3>
Last quarter the company beat on EPS by $0.01 which was followed by a 5.0% increase in the share price the next day.
Here's a look at Triumph Financial's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.18</td>
<td>0.22</td>
<td>0.34</td>
<td>0.40</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.19</td>
<td>0.08</td>
<td>0.14</td>
<td>0.37</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>107.30M</td>
<td>104.08M</td>
<td>106.01M</td>
<td>106.85M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>106.20M</td>
<td>105.08M</td>
<td>101.03M</td>
<td>106.15M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Triumph Financial <a href="https://www.benzinga.com/quote/TFIN/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TFIN

Triumph Financial Earnings Analysis: Q4 Recap

Towne Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOWN#NASDAQ">TOWN</a>) reported quarterly earnings of $0.55 per share which beat the analyst consensus estimate of $0.48 by 14.58 percent. This is a 30.95 percent increase over earnings of $0.42 per share from the same period last year. The company reported quarterly sales of $177.16 million which beat the analyst consensus estimate of $170.78 million by 3.74 percent. This is a 13.90 percent increase over sales of $155.55 million the same period last year.

Earnings Beats

TOWN

Towne Bank Q4 Adj $0.55 Beats $0.48 Estimate, Sales $177.16M Beat $170.78M Estimate

The earnings results for SL Green Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLG#NYSE">SLG</a>) for Q4 were made public on Wednesday, January 22, 2025 at 04:10 PM.
Here's a comprehensive overview of the announcement.
<h3>Earnings</h3>
SL Green Realty beat estimated earnings by 18.0%, reporting an EPS of $1.81 versus an estimate of $1.53.
Revenue was up $7.69 million from the same period last year.
<h3>Earnings History Overview</h3>
In the previous quarter, the company missed on EPS by $0.07, resulting in a 3.0% increase change in the share price the following day.
Here's a look at SL Green Realty's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.20</td>
<td>1.60</td>
<td>2.16</td>
<td></td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.13</td>
<td>2.05</td>
<td>3.07</td>
<td>0.72</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>136.66M</td>
<td>149.28M</td>
<td>152.67M</td>
<td>161.36M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>139.62M</td>
<td>135.56M</td>
<td>128.20M</td>
<td>131.93M</td>
</tr>
</tbody>
</table>

To track all earnings releases for SL Green Realty <a href="https://www.benzinga.com/quote/SLG/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SL Green Realty Q4 Earnings Assessment

The Q4 earnings report for Hexcel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HXL#NYSE">HXL</a>) was released on Wednesday, January 22, 2025 at 04:15 PM.
Here's what investors need to know about the latest announcement.
<h3>Earnings</h3>
Hexcel missed estimated earnings by 0.0%, reporting an EPS of $0.52 versus an estimate of $0.52.
Revenue was up $16.30 million from the same period last year.
<h3>Historical Earnings Summary</h3>
During the previous quarter, the company beat on EPS by $0.01, leading to a 1.0% increase share price change the next day.
Here's a look at Hexcel's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.46</td>
<td>0.56</td>
<td>0.41</td>
<td>0.49</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.47</td>
<td>0.60</td>
<td>0.44</td>
<td>0.43</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>456.90M</td>
<td>483.36M</td>
<td>473.78M</td>
<td>471.69M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>456.50M</td>
<td>500.40M</td>
<td>472.30M</td>
<td>457.50M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Hexcel <a href="https://www.benzinga.com/quote/HXL/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights into Hexcel Q4 Earnings

The earnings results for Plexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) for Q1 were made public on Wednesday, January 22, 2025 at 04:15 PM.
Here's a comprehensive overview of the announcement.
<h3>Earnings</h3>
Plexus beat estimated earnings by 9.0%, reporting an EPS of $1.73 versus an estimate of $1.59.
Revenue was down $6.88 million from the same period last year.
<h3>Past Earnings Performance</h3>
The company beat on EPS by $0.3 in the last quarter, resulting in a 7.000000000000001% increase share price change the following day.
Here's a look at Plexus's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.55</td>
<td>1.30</td>
<td>0.87</td>
<td>1.08</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.85</td>
<td>1.45</td>
<td>0.94</td>
<td>1.04</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.01B</td>
<td>981.25M</td>
<td>950.83M</td>
<td>987.63M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.05B</td>
<td>961.00M</td>
<td>967.00M</td>
<td>983.00M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Plexus management provided guidance for Q2 2025, expecting earnings between $1.46 and $1.61 per share.
To track all earnings releases for Plexus <a href="https://www.benzinga.com/quote/PLXS/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PLXS

Plexus: Q1 Earnings Insights

National Bank Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBHC#NYSE">NBHC</a>) released its Q4 earnings on Wednesday, January 22, 2025 at 04:10 PM.
Here's what's important from the earnings announcement.
<h3>Earnings</h3>
National Bank Holdings beat estimated earnings by 12.0%, reporting an EPS of $0.86 versus an estimate of $0.77.
Revenue was up $600 thousand from the same period last year.
<h3>Overview of Past Earnings</h3>
During the previous quarter, the company beat on EPS by $0.11, leading to a 8.0% increase share price change the next day.
Here's a look at National Bank Holdings's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.75</td>
<td>0.74</td>
<td>0.76</td>
<td>0.82</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.86</td>
<td>0.68</td>
<td>0.82</td>
<td>0.87</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>104.59M</td>
<td>102.96M</td>
<td>103.68M</td>
<td>103.96M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>106.04M</td>
<td>97.60M</td>
<td>101.72M</td>
<td>107.23M</td>
</tr>
</tbody>
</table>

To track all earnings releases for National Bank Holdings <a href="https://www.benzinga.com/quote/NBHC/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

NBHC

Earnings Breakdown: National Bank Holdings Q4

CACI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>) reported its Q2 earnings results on Wednesday, January 22, 2025 at 04:15 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
CACI International beat estimated earnings by 13.0%, reporting an EPS of $5.95 versus an estimate of $5.25.
Revenue was up $266.00 million from the same period last year.
<h3>Previous Earnings Records</h3>
The company beat on EPS by $0.86 in the last quarter, resulting in a 5.0% increase share price change the following day.
Here's a look at CACI International's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>5.07</td>
<td>5.93</td>
<td>5.63</td>
<td>4.47</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>5.93</td>
<td>6.61</td>
<td>5.74</td>
<td>4.36</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.92B</td>
<td>1.93B</td>
<td>1.86B</td>
<td>1.84B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>2.06B</td>
<td>2.04B</td>
<td>1.94B</td>
<td>1.83B</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
CACI International management provided guidance for FY 2025, expecting earnings between $23.87 and $24.76 per share.
To track all earnings releases for CACI International <a href="https://www.benzinga.com/quote/CACI/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CACI

CACI International Earnings Review: Q2 Summary

Third Coast Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBX#NASDAQ">TCBX</a>) reported its Q4 earnings results on Wednesday, January 22, 2025 at 04:15 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Third Coast Bancshares beat estimated earnings by 14.000000000000002%, reporting an EPS of $0.79 versus an estimate of $0.69.
Revenue was up $6.82 million from the same period last year.
<h3>Performance in Previous Earnings</h3>
Last quarter the company beat on EPS by $0.2 which was followed by a 6.0% increase in the share price the next day.
Here's a look at Third Coast Bancshares's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.54</td>
<td>0.57</td>
<td>0.49</td>
<td>0.48</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.74</td>
<td>0.63</td>
<td>0.61</td>
<td>0.57</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>41.67M</td>
<td>41.13M</td>
<td>39.30M</td>
<td>38.13M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>42.90M</td>
<td>41.75M</td>
<td>40.42M</td>
<td>39.49M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Third Coast Bancshares <a href="https://www.benzinga.com/quote/TCBX/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TCBX

Third Coast Bancshares Q4 Earnings Assessment

The earnings results for Wesbanco (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WSBC#NASDAQ">WSBC</a>) for Q4 were made public on Wednesday, January 22, 2025 at 04:15 PM.
Here's a comprehensive overview of the announcement.
<h3>Earnings</h3>
Wesbanco beat estimated earnings by 28.999999999999996%, reporting an EPS of $0.71 versus an estimate of $0.55.
Revenue was up $8.75 million from the same period last year.
<h3>Earnings History Overview</h3>
In the previous quarter, the company beat on EPS by $0.05, resulting in a 1.0% drop change in the share price the following day.
Here's a look at Wesbanco's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.51</td>
<td>0.53</td>
<td>0.55</td>
<td>0.56</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.56</td>
<td>0.49</td>
<td>0.56</td>
<td>0.55</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>120.74M</td>
<td>126.11M</td>
<td>116.83M</td>
<td>116.77M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>121.14M</td>
<td>116.59M</td>
<td>113.97M</td>
<td>117.76M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Wesbanco <a href="https://www.benzinga.com/quote/WSBC/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

WSBC

Wesbanco Earnings Analysis: Q4 Recap

Univest Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UVSP#NASDAQ">UVSP</a>) reported its Q4 earnings results on Wednesday, January 22, 2025 at 04:15 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Univest Financial beat estimated earnings by 14.000000000000002%, reporting an EPS of $0.65 versus an estimate of $0.57.
Revenue was up $5.42 million from the same period last year.
<h3>Previous Earnings Records</h3>
Last quarter the company beat on EPS by $0.09 which was followed by a 4.0% increase in the share price the next day.
Here's a look at Univest Financial's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.54</td>
<td>0.51</td>
<td>0.51</td>
<td>0.47</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.63</td>
<td>0.61</td>
<td>0.60</td>
<td>0.55</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>73.20M</td>
<td>72.30M</td>
<td>72.20M</td>
<td>71.25M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>73.35M</td>
<td>72.01M</td>
<td>77.06M</td>
<td>71.38M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Univest Financial <a href="https://www.benzinga.com/quote/UVSP/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

UVSP

Univest Financial Earnings Review: Q4 Summary

Equity Bancshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQBK#NYSE">EQBK</a>) just disclosed its Q4 earnings on Wednesday, January 22, 2025 at 04:45 PM.
Here's a brief overview of the earnings report.
<h3>Earnings</h3>
Equity Bancshares beat estimated earnings by 13.0%, reporting an EPS of $1.04 versus an estimate of $0.92.
Revenue was up $62.24 million from the same period last year.
<h3>Performance in Previous Earnings</h3>
In the previous quarter, the company beat on EPS by $0.32, resulting in a 2.0% increase change in the share price the following day.
Here's a look at Equity Bancshares's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.99</td>
<td>0.92</td>
<td>0.85</td>
<td>-1.88</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.31</td>
<td>0.99</td>
<td>0.90</td>
<td>-1.84</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>56.09M</td>
<td>55.15M</td>
<td>52.81M</td>
<td>29.49M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>55.35M</td>
<td>55.43M</td>
<td>55.91M</td>
<td>-3M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Equity Bancshares <a href="https://www.benzinga.com/quote/EQBK/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EQBK

Earnings Breakdown: Equity Bancshares Q4

Shares of solar stocks, including First Solar Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) and SolarEdge Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) were volatile Wednesday as investors reacted to President Donald Trump&#8217;s newly signed <a href="https://www.benzinga.com/25/01/43109461/gold-miners-defense-stocks-shine-while-solar-tanks-following-trumps-day-1-actions">executive orders promoting </a>fossil fuels and reversing climate-focused policies.
What To Know: The sell-off followed Trump's inauguration and his immediate signature on executive orders prioritizing oil and gas development over renewable energy initiatives.
According to<a href="https://www.nytimes.com/2025/01/20/climate/trump-emergency-oil-gas.html"> the New York Times</a>, his administration announced plans to withdraw from the Paris Agreement, expand fossil fuel drilling on public lands and waters, and eliminate regulatory support for electric vehicles and renewable energy projects. Trump also declared a national energy emergency aimed at accelerating fossil fuel production, further unsettling renewable energy investors.
The market&#8217;s response may reflect concerns over the new administration's shift in energy policy, which contrasts sharply with the pro-renewable initiatives under the previous Biden administration. Analysts believe this pivot could slow the growth of the renewable energy sector and significantly impact solar companies, contributing to the downward pressure on their stock prices.
Price Action: First Solar&#8217;s stock closed Wednesday at $171.90, down 6.33%, and SolarEdge Technologies closed at $13.05, down 4.74%, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43144023/riot-stock-poised-break-out-consolidation-cycle">Options Corner: Riot Platforms Could Be Itching To Charge Higher</a></li>
</ul>
Photo: solarseven on Shutterstock.

Government

FSLR

SEDG

Solar Shares Are Volatile Today: What's Going On?

CVB Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVBF#NASDAQ">CVBF</a>) reported quarterly earnings of $0.36 per share which beat the analyst consensus estimate of $0.34 by 5.88 percent. This is a 7.69 percent decrease over earnings of $0.39 per share from the same period last year.

CVBF

CVB Financial Q4 EPS $0.36 Beats $0.34 Estimate

WIIM

BETR

Better Home & Finance shares are trading higher after the company announced a $25 million share repurchase program.

Jean Madar, Chairman &amp; Chief Executive Officer of Interparfums, stated, "Our net sales in the final quarter of 2024 marked our best-ever fourth quarter performance, with quarterly sales growth of 10%, enabling us to achieve our 2024 sales goal of $1.45 billion."
Achieving the sales goal of $1.45 billion positions the Company to meet its full year 2024 earnings per diluted share target of $5.15, excluding a supplemental non-recurring, non-cash impairment charge of approximately $0.07 per diluted share, associated with trademarks.

Guidance

IPAR

Interparfums Q4 Net Sales Up 10% To $362M, Est $361.807M

Macro Economic Events

Econ #s

Economics

API Weekly Crude Stock: 1M Barrel Build

Knight-Swift (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNX#NYSE">KNX</a>) reported its Q4 earnings results on Wednesday, January 22, 2025 at 04:02 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Knight-Swift beat estimated earnings by 9.0%, reporting an EPS of $0.36 versus an estimate of $0.33.
Revenue was down $67.72 million from the same period last year.
<h3>Earnings History Overview</h3>
The company beat on EPS by $0.02 in the previous quarter, leading to a 2.0% drop share price change the next day.
Here's a look at Knight-Swift's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.32</td>
<td>0.28</td>
<td>0.20</td>
<td>0.44</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.34</td>
<td>0.24</td>
<td>0.12</td>
<td>0.09</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.91B</td>
<td>1.83B</td>
<td>1.82B</td>
<td>1.97B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.88B</td>
<td>1.85B</td>
<td>1.82B</td>
<td>1.93B</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Knight-Swift management provided guidance for Q2 2025, expecting earnings between $0.46 and $0.5 per share.
To track all earnings releases for Knight-Swift <a href="https://www.benzinga.com/quote/KNX/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Knight-Swift: Q4 Earnings Insights

Fourth Quarter and Full Year 2024 Preliminary Results
For the fourth quarter 2024, Concentra expects to report:
<ul>
<li>Revenue of $465.0 million, an increase of 5.5% over Q4 2023</li>
<li>Net income in the range of $20.6 million to $22.6 million, compared to $28.9 million in Q4 2023</li>
<li>Adjusted EBITDA of $77.5 million, an increase of 13.6% over Q4 2023</li>
<li>Patient Visits of 2,994,988, or 46,797 Visits per Day, a decrease in Visits per Day of 2.1% from Q4 2023</li>
<li>Revenue per Visit of $145.08, an increase of 5.8% over Q4 2023</li>
<li>Capital Expenditures of $18.1 million, compared to $23.6 million in Q4 2023</li>
<li>Total occupational health centers of 552, compared to 544 at end of Q4 2023</li>
<li>Total onsite health clinics of 157, compared to 150 at end of Q4 2023</li>
</ul>
For full year 2024, Concentra expects to report:
<ul>
<li>Revenue of $1,900.2 million, an increase of 3.4% over FY 2023</li>
<li>Net income in the range of $169.7 million to $171.7 million, compared to $184.7 million in FY 2023</li>
<li>Adjusted EBITDA of $376.9 million, an increase of 4.3% over FY 2023</li>
<li>Cash balance of $183.3 million and net leverage ratio of approximately 3.5x</li>
<li>Patient Visits of 12,623,503, or 49,311 Visits per Day in the quarter, a decrease in Visits per Day of 2.0% from FY 2023</li>
<li>Revenue per Visit of $141.30, an increase of 4.5% over FY 2023</li>
<li>Capital Expenditures of $65.7 million, compared to $65.0 million in FY 2023</li>
</ul>

Concentra Announces Preliminary Q4 2024 Revenue Of $465M, Up 5.5%, Net Income $20.6M-$22.6M; FY24 Revenue $1.9B, Up 3.4%, Net Income $169.7M-$171.7M; Q4 Adjusted EBITDA Up 13.6% To $77.5M; FY Adjusted EBITDA Up 4.3% To $376.9M; Patient Visits Down 2.1%; CapEx $18.1M In Q4

The earnings results for QCR Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCRH#NASDAQ">QCRH</a>) for Q4 were made public on Wednesday, January 22, 2025 at 04:05 PM.
Here's a comprehensive overview of the announcement.
<h3>Earnings</h3>
QCR Hldgs beat estimated earnings by 10.0%, reporting an EPS of $1.93 versus an estimate of $1.76.
Revenue was up $5.47 million from the same period last year.
<h3>Earnings History Overview</h3>
The company beat on EPS by $0.26 in the previous quarter, leading to a 0.0% increase share price change the next day.
Here's a look at QCR Hldgs's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.52</td>
<td>1.40</td>
<td>1.30</td>
<td>1.35</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.78</td>
<td>1.73</td>
<td>1.59</td>
<td>1.97</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>61.47M</td>
<td>65.25M</td>
<td>63.77M</td>
<td>58.53M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>59.72M</td>
<td>56.16M</td>
<td>54.70M</td>
<td>55.74M</td>
</tr>
</tbody>
</table>

To track all earnings releases for QCR Hldgs <a href="https://www.benzinga.com/quote/QCRH/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Summary: QCR Hldgs Q4

Press Releases

Argentum 47, Inc. Announces Acquisition of Marelius Biopharma Group, Divestiture of Argentum Data Solutions, and Leadership Transition

Argentum 47

During Thursday&#39;s morning trading, 35 companies set new 52-week lows.

<h3>Noteworthy Mentions:</h3>

<ul>
	<li>Allianz&nbsp;(OTC:<a class="ticker" href="/stock/ALIZY#OTC">ALIZY</a>)&nbsp;was the biggest company on a market cap basis to set a new 52-week low.</li>
	<li>The smallest company by market cap to set a new 52-week low was&nbsp;Minerco&nbsp;(OTC:<a class="ticker" href="/stock/MINE#OTC">MINE</a>).</li>
	<li>Advanced Oncotherapy&nbsp;(OTC:<a class="ticker" href="/stock/AONCF#OTC">AONCF</a>)&nbsp;saw the biggest bounce back on, as shares traded up 0.12% to rebound after it hit its new 52-week low.</li>
</ul>

Stocks dropping to new 52-week lows as of 10 a.m. ET on Thursday:

<ul>
	<li>Allianz&nbsp;(OTC:<a class="ticker" href="/stock/ALIZY#OTC">ALIZY</a>)&nbsp;stock moved down 0.25% over Thursday&#39;s trading session after setting a new 52-week low of $24.17 to open trading.</li>
	<li>Orange&nbsp;(NYSE:<a class="ticker" href="/stock/ORAN#NYSE">ORAN</a>)&nbsp;shares set a new yearly low of $14.30 this morning. The stock was down 1.99% on the session.</li>
	<li>Renault&nbsp;(OTC:<a class="ticker" href="/stock/RNLSY#OTC">RNLSY</a>)&nbsp;stock hit a yearly low of $8.74 this morning. The stock was down 1.64% for the day.</li>
	<li>Chr. Hansen Holding&nbsp;(OTC:<a class="ticker" href="/stock/CHYHY#OTC">CHYHY</a>)&nbsp;stock hit a yearly low of $18.50 this morning. The stock was down 0.17% for the day.</li>
	<li>Pearson&nbsp;(NYSE:<a class="ticker" href="/stock/PSO#NYSE">PSO</a>)&nbsp;stock fell to a new 52-week low on Thursday morning at $7.33, and later moved down 8.76% over the session.</li>
	<li>Bombardier&nbsp;(OTC:<a class="ticker" href="/stock/BDRBF#OTC">BDRBF</a>)&nbsp;stock moved down 33.57% over Thursday&#39;s trading session after setting a new 52-week low of $1.13 to open trading.</li>
	<li>Bombardier&nbsp;(OTC:<a class="ticker" href="/stock/BDRAF#OTC">BDRAF</a>)&nbsp;shares set a new 52-week low of $1.05 today morning. The stock traded down 34.31% over the session.</li>
	<li>Cantel Medical&nbsp;(NYSE:<a class="ticker" href="/stock/CMD#NYSE">CMD</a>)&nbsp;shares fell to $60.21 on Thursday morning, setting a new 52-week low. Shares then moved down 0.95%.</li>
	<li>Qudian&nbsp;(NYSE:<a class="ticker" href="/stock/QD#NYSE">QD</a>)&nbsp;shares set a new yearly low of $3.63 this morning. The stock was down 12.8% on the session.</li>
	<li>Halfords Group&nbsp;(OTC:<a class="ticker" href="/stock/HLFDF#OTC">HLFDF</a>)&nbsp;stock set a new 52-week low of $2.06 on Thursday morning, with shares later moving down 1.9%.</li>
	<li>Advanced Oncotherapy&nbsp;(OTC:<a class="ticker" href="/stock/AONCF#OTC">AONCF</a>)&nbsp;stock moved down 29.69% over Thursday&#39;s trading session after setting a new 52-week low of $0.45 to open trading.</li>
	<li>Cansortium&nbsp;(OTC:<a class="ticker" href="/stock/CNTMF#OTC">CNTMF</a>)&nbsp;stock set a new 52-week low of $0.24 on Thursday morning, with shares later moving up 0.12%.</li>
	<li>Lixte Biotech Holdings&nbsp;(OTC:<a class="ticker" href="/stock/LIXT#OTC">LIXT</a>)&nbsp;shares fell to $0.56 on Thursday morning, setting a new 52-week low. Shares then moved down 18.0%.</li>
	<li>iMedia Brands&nbsp;(NASDAQ:<a class="ticker" href="/stock/IMBI#NASDAQ">IMBI</a>)&nbsp;stock hit a yearly low of $2.87 this morning. The stock was down 2.73% for the day.</li>
	<li>Kewaunee Scientific&nbsp;(NASDAQ:<a class="ticker" href="/stock/KEQU#NASDAQ">KEQU</a>)&nbsp;stock fell to a new 52-week low on Thursday morning at $12.60, and later moved down 0.16% over the session.</li>
	<li>Blue Dolphin Energy&nbsp;(OTC:<a class="ticker" href="/stock/BDCO#OTC">BDCO</a>)&nbsp;stock moved down 14.63% over Thursday&#39;s trading session after setting a new 52-week low of $0.39 to open trading.</li>
	<li>Engold Mines&nbsp;(OTC:<a class="ticker" href="/stock/GWRRF#OTC">GWRRF</a>)&nbsp;shares fell to $0.04 on Thursday morning, setting a new 52-week low. Shares then moved down 13.68%.</li>
	<li>Sienna Biopharmaceuticals&nbsp;(OTC:<a class="ticker" href="/stock/SNNAQ#OTC">SNNAQ</a>)&nbsp;shares reached a new 52-week low of $0.03 on Thursday morning, later moving down 1.87% over the rest of the day.</li>
	<li>Garb Oil &amp; Power&nbsp;(OTC:<a class="ticker" href="/stock/GARB#OTC">GARB</a>)&nbsp;stock hit a yearly low of $0.000001 this morning. The stock was down 99.0% for the day.</li>
	<li>Goliath Resources&nbsp;(OTC:<a class="ticker" href="/stock/GOTRF#OTC">GOTRF</a>)&nbsp;shares were down 48.0% over the session, having began the day with a 52-week low of $0.01.</li>
	<li>Orchid Ventures&nbsp;(OTC:<a class="ticker" href="/stock/ORVRF#OTC">ORVRF</a>)&nbsp;stock set a new 52-week low of $0.02 on Thursday morning, with shares later moving down 30.12%.</li>
	<li>Argentum 47&nbsp;(OTC:<a class="ticker" href="/stock/ARGQ#OTC">ARGQ</a>)&nbsp;shares set a new 52-week low of $0.00165 today morning. The stock traded down 18.18% over the session.</li>
	<li>Eco Allies&nbsp;(OTC:<a class="ticker" href="/stock/SVSN#OTC">SVSN</a>)&nbsp;stock dropped to a yearly low on Thursday morning of $0.01. Shares then traded down 64.12%.</li>
	<li>Coroware&nbsp;(OTC:<a class="ticker" href="/stock/COWI#OTC">COWI</a>)&nbsp;stock fell to a new 52-week low on Thursday morning at $0.000001, and later moved 0.0% (flat) over the session.</li>
	<li>FutureLand&nbsp;(OTC:<a class="ticker" href="/stock/FUTL#OTC">FUTL</a>)&nbsp;stock fell to a new 52-week low of $0.000001 on Thursday morning. Shares of the company traded 0.0% (flat) on the day.</li>
	<li>Frontline Gold&nbsp;(OTC:<a class="ticker" href="/stock/FLDPF#OTC">FLDPF</a>)&nbsp;shares hit a yearly low of $0.0008 today morning. The stock was down 70.37% on the session.</li>
	<li>United American&nbsp;(OTC:<a class="ticker" href="/stock/UAMA#OTC">UAMA</a>)&nbsp;stock hit $0.03 on Thursday morning, setting a new 52-week low. The stock traded 0.0% (flat) over the course of the day.</li>
	<li>Gold Rush Cariboo&nbsp;(OTC:<a class="ticker" href="/stock/SGRWF#OTC">SGRWF</a>)&nbsp;stock hit a new 52-week low of $0.00333 to begin trading. The stock was 0.0% (flat) on the session.</li>
	<li>Innerscope Hearing Techno&nbsp;(OTC:<a class="ticker" href="/stock/INND#OTC">INND</a>)&nbsp;shares began trading with a new 52-week low of $0.0007 on Thursday. The stock was 0.0% (flat) for the day.</li>
	<li>High Performance&nbsp;(OTC:<a class="ticker" href="/stock/TBEV#OTC">TBEV</a>)&nbsp;shares were 0.0% (flat) over the session, having began the day with a 52-week low of $0.000001.</li>
	<li>Tiger Oil and Energy&nbsp;(OTC:<a class="ticker" href="/stock/TGRO#OTC">TGRO</a>)&nbsp;stock dropped to a yearly low on Thursday morning of $0.000001. Shares then traded down 99.0%.</li>
	<li>APT Systems&nbsp;(OTC:<a class="ticker" href="/stock/APTY#OTC">APTY</a>)&nbsp;shares set a new 52-week low of $0.0001 today morning. The stock traded 0.0% (flat) over the session.</li>
	<li>Health Sciences Group&nbsp;(OTC:<a class="ticker" href="/stock/HESG#OTC">HESG</a>)&nbsp;stock fell to a new 52-week low on Thursday morning at $0.000001, and later moved 0.0% (flat) over the session.</li>
	<li>Arista Financial&nbsp;(OTC:<a class="ticker" href="/stock/ARST#OTC">ARST</a>)&nbsp;shares were 0.0% (flat) over the session, having began the day with a 52-week low of $0.00045.</li>
	<li>Minerco&nbsp;(OTC:<a class="ticker" href="/stock/MINE#OTC">MINE</a>)&nbsp;shares were down 99.0% over the session, having began the day with a 52-week low of $0.000001.</li>
</ul>

 
Benzinga will update traders on these companies going forward. If these companies break to a new level, Benzinga will be the first to report on it.

Comments

Argentum 47

News

Latest news for Argentum 47 (OTC:ARGQ) Stock

Thursday, January 16, 2020

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga